Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...

Amgen's Q4 earnings beat expectations, showcasing robust performance for the company's growth strategy. Click here to read ...

Neurocrine Biosciences (($NBIX)) has held its Q4 earnings call. Read on for the main highlights of the call. Neurocrine Biosciences’ earnings call ...

Canada’s Trans Mountain oil pipeline, which allows producers to sell crude to markets in Asia, could fill to capacity as ...

AMETEK achieved record quarterly sales of $1.76B, a 2% increase year-over-year. Operating income reached $469M, up 5%, with operating margins expanding by 90 basis points to 26.6%. Diluted EPS stood ...

Pharmaceutical giant GlaxoSmithKline (GSK) has lifted its long-term sales guidance as it hailed a strong drug pipeline.

GSK Plc plans to buy back £2 billion ($2.5 billion) of shares as it raised its long-term growth outlook on optimism around ...

GSK shares surge as the drugmaker raises its 2031 sales target to over £40bn, boosts dividends, and announces a £2bn share ...

Learn more about whether Cameco Corporation or Pembina Pipeline Corporation is a better investment based on AAII's A+ ...

Learn more about whether Pembina Pipeline Corporation or TC Energy Corporation is a better investment based on AAII's A+ ...

Robert Bradway, chairman and CEO said, “Robust growth in sales and earnings throughout 2024 reflects the momentum of our business. With strong ...

These launches are positioned for multi-blockbuster status, thanks to their promise of fulfilling unmet needs, impacting ...